首页> 外文期刊>The Psychiatric quarterly >Lamotrigine in the treatment of unipolar depression with and without comorbidities: A literature review
【24h】

Lamotrigine in the treatment of unipolar depression with and without comorbidities: A literature review

机译:拉莫三嗪治疗合并或不合并合并症的单相抑郁症:文献综述

获取原文
获取原文并翻译 | 示例
           

摘要

To review the available data behind the use of lamotrigine in unipolar depression and common comorbid conditions. A PubMed based literature review was conducted using keywords related to lamotrigine, depression, anxiety, post traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and personality disorders. A large number of trials using lamotrigine for unipolar depression and various comorbid conditions were reviewed. A major limitation behind the majority of studies was a limited course of the treatment phase. The most robust data was found among studies that followed patients for over 8 weeks, and used higher dosages. Patients with comorbid anxiety states appeared to benefit. Patients with borderline personality disorder also appeared to benefit. The benefits of lamotrigine in unipolar depression have been inconsistently noted in a number of studies. This is due in part to short treatment phases, atypical domains of benefit and different patient populations across studies. Patients with more treatment-resistance, comorbid anxiety and borderline personality disorder may be more able to benefit from lamotrigine.
机译:回顾在单相抑郁症和常见合并症中使用拉莫三嗪背后的可用数据。基于PubMed的文献综述使用了与拉莫三嗪,抑郁症,焦虑症,创伤后应激障碍(PTSD),强迫症(OCD)和人格障碍相关的关键字。回顾了使用拉莫三嗪治疗单相抑郁症和各种合并症的大量试验。大多数研究的主要局限性在于治疗阶段的过程有限。在追踪患者超过8周并使用更高剂量的研究中发现了最可靠的数据。患有合并症的患者似乎受益。边缘性人格障碍患者也似乎受益。在许多研究中不一致地指出了拉莫三嗪在单相抑郁症中的益处。这部分是由于治疗期短,受益的非典型性领域以及整个研究中的不同患者人群所致。耐药性更高,合并症,边缘性人格障碍的患者可能更能从拉莫三嗪中获益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号